Since the average treatment effect (ATE) measures the change in social welfare, even if positive, there is a risk of negative effect on, say, some 10% of the population. Assessing such risk is difficult, however, because any one individual treatment effect (ITE) is never observed, so the 10% worst-affected cannot be identified, while distributional treatment effects only compare the first deciles within each treatment group, which does not correspond to any 10%-subpopulation. In this paper we consider how to nonetheless assess this important risk measure, formalized as the conditional value at risk (CVaR) of the ITE-distribution. We leverage the availability of pre-treatment covariates and characterize the tightest-possible upper and lower bounds on ITE-CVaR given by the covariate-conditional average treatment effect (CATE) function. We then proceed to study how to estimate these bounds efficiently from data and construct confidence intervals. This is challenging even in randomized experiments as it requires understanding the distribution of the unknown CATE function, which can be very complex if we use rich covariates so as to best control for heterogeneity. We develop a debiasing method that overcomes this and prove it enjoys favorable statistical properties even when CATE and other nuisances are estimated by black-box machine learning or even inconsistently. Studying a hypothetical change to French job-search counseling services, our bounds and inference demonstrate a small social benefit entails a negative impact on a substantial subpopulation.
翻译:由于平均治疗效果(ATE)衡量社会福利的变化,即使是积极的,也有可能对大约10%的人口产生负面效应。但是,评估这种风险是困难的,因为从未观察到任何一种个别治疗效果(ITE),因此无法确定10%受影响最重的治疗效果,而分配治疗效果只是比较每个治疗组中的第一个十分位数,这与任何10%的子人口不相称。在本文件中,我们考虑如何评估这一重要的风险评估措施,正式确定为ITE分配的有条件风险值(CVaR)。我们利用预治疗变变异的可能性来评估这种风险风险值。我们利用预处理变异的可能性来评估这种风险风险风险值。我们利用预变异性变异性变异性变异性变异性对ITE-CVaR最接近的上下限值(ITETE)的特性,因为共变异性平均治疗效果(CATE)功能给ITE-CaR造成最接近的上下限值,因此无法辨别。我们接着研究如何从数据中有效地估计这些界限,这甚至需要理解未知的CATE(CATE)功能的变异性变异性变异性变现。我们通过一种最难的统计学方法来评估一种最有利于性变换。我们的方法来研究。